Can MS Damage Be Reversed? Exploring Novel Interventions
In a newly published systematic review of clinical trials, researchers evaluated the safety and efficacy of interventions aimed at promoting remyelination in multiple sclerosis (MS), a neurodegenerative disease characterized by inflammation, demyelination, and axonal damage in the central nervous system.